| P50 | author | Huile Gao | Q56954141 |
| | Rui Ran | Q88352252 |
| P2093 | author name string | Li Zhang | |
| | Jie Tang | |
| | Yayuan Liu | |
| | Zhirong Zhang | |
| | Qin He | |
| | Han Fu | |
| | Qianyu Zhang | |
| | Qifang Kuang | |
| P2860 | cites work | "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes | Q40047721 |
| | Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system | Q40048084 |
| | A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating | Q40297920 |
| | Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT. | Q42284063 |
| | "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers | Q42544966 |
| | Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge | Q42923797 |
| | Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor | Q43253913 |
| | Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection | Q44118023 |
| | Low-pH-sensitive PEG-stabilized plasmid-lipid nanoparticles: preparation and characterization | Q44132222 |
| | Effects of phospholipid composition on MinD-membrane interactions in vitro and in vivo | Q44391306 |
| | Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives | Q46460581 |
| | Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | Q46515132 |
| | Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic | Q46672743 |
| | Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery | Q48971803 |
| | Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes. | Q50971865 |
| | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery | Q31577177 |
| | Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. | Q33654515 |
| | Cell-penetrating peptides: breaking through to the other side | Q34032300 |
| | Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration | Q34043777 |
| | Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). | Q34129417 |
| | Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting | Q34500552 |
| | Targeting of lipid vesicles: specificity of carbohydrate receptor analogues for leukocytes in mice | Q36400189 |
| | Tumour-targeted nanomedicines: principles and practice. | Q36858135 |
| | The design of guanidinium-rich transporters and their internalization mechanisms. | Q37047226 |
| | Drug targeting and tumor heterogeneity | Q37064520 |
| | Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking. | Q37074531 |
| | Nanoparticles evading the reticuloendothelial system: role of the supported bilayer | Q37376443 |
| | Nanosystem drug targeting: Facing up to complex realities | Q37628871 |
| | Targeting nanoparticles to cancer. | Q37728139 |
| | Immunoconjugates and long circulating systems: origins, current state of the art and future directions | Q38042256 |
| | Arginine-rich peptides: methods of translocation through biological membranes | Q38058882 |
| | Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity | Q39425556 |
| | Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery | Q39568717 |
| | A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. | Q39693978 |
| | Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors | Q39854481 |
| | PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake | Q39899786 |
| | In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells | Q39931690 |
| | Determinants for in vivo anti-tumor effects of PEG liposomal doxorubicin: importance of vascular permeability within tumors | Q39986763 |
| P433 | issue | 4 | |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 313-326 | |
| P577 | publication date | 2014-01-09 | |
| P1433 | published in | Journal of Drug Targeting | Q6295099 |
| P1476 | title | Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery | |
| P478 | volume | 22 | |